Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Some of the key events about Novartis
- 1996Formed through the merger of Ciba-Geigy and Sandoz, creating one of the world's largest pharmaceutical companies
- 1996Faced criticism for conducting unethical clinical trials in Nigeria during a meningitis outbreak
- 2000Developed Gleevec, a groundbreaking treatment for chronic myeloid leukemia
- 2003Launched the Novartis Institute for Tropical Diseases to research treatments for neglected diseases
- 2005Paid $225 million to settle allegations of Medicaid fraud in the United States
- 2006Introduced Exforge, a combination drug for hypertension treatment
- 2010Acquired Alcon, expanding its presence in eye care products
- 2010Agreed to pay $422.5 million to resolve criminal and civil liability for off-label promotion of certain drugs
- 2012Received FDA approval for Afinitor to treat breast cancer
- 2013Settled a gender discrimination lawsuit for $152.5 million in the United States
- 2015Completed a series of strategic transactions with GlaxoSmithKline, strengthening its position in key areas
- 2015Paid $390 million to settle charges of giving kickbacks to specialty pharmacies in the US
- 2016Agreed to pay $25 million to resolve an SEC investigation into bribery in China
- 2017Received FDA approval for Kymriah, the first CAR-T cell therapy for certain types of cancer
- 2018Acquired AveXis, enhancing its gene therapy capabilities
- 2018Faced scrutiny for paying $1.2 million to a company owned by President Trump's personal lawyer
- 2019Concealed manipulated data from the FDA during the approval process for gene therapy Zolgensma
- 2020Committed to donating up to 130 million doses of hydroxychloroquine for COVID-19 research
- 2020Agreed to pay over $729 million to settle US kickback allegations
- 2022Recalled certain Sandoz generic drugs due to packaging issues that could affect drug stability
Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.
Novartis Latest news
Popular
Blinken Voices Concern Over Escalations Threatening Gaza Cease-fire Talks
U.S. Lawmakers Push to Renew Global Fragility Act Amid African Security Concerns
Kentucky Governor Bans Conversion Therapy for Minors via Executive Order
Washington Post Reporter Shifts Focus to Community Impact of D.C. Policies
Lebanon's Healthcare System Faces Critical Test Amid Ongoing Crises
Maryland's Drug Discount Law Survives Legal Challenge from Pharma Giants
A federal judge upholds Maryland's law mandating drug discounts for low-income populations, rejecting pharmaceutical companies' bid to block it. This decision impacts the ongoing debate over the 340B program nationwide.
Global Pharma Giants Eye Chinese Market Despite Geopolitical Tensions
Major pharmaceutical companies are actively seeking acquisitions in China, despite Sino-U. S. tensions. This trend highlights the strategic importance of the Chinese market for global drugmakers.